Deborah T. Blumenthal

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert, James J. Dignam, Terri S. Armstrong et al. · New England Journal of Medicine · 2014 · 2.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Medicine, Oncology, Pharmacology +13

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

Mark R. Gilbert, Meihua Wang, Kenneth Aldape et al. · Journal of Clinical Oncology · 2013 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +17

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal et al. · New England Journal of Medicine · 2023 · 719 citations · Full text

Medicine, Neurology, Oncology +8

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

Haley Gittleman, D. Lim, Michael W. Kattan et al. · Neuro-Oncology · 2016 · 174 citations · Full text

Medicine, Biostatistics, Oncology +16